Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

JAKINIB Study: " 'Observational', Multicentre Trial Collecting Prospective and On-going Clinical and Laboratory Data for Patients Treated With JAK Inhibitors for Inflammatory Rheumatism According to EMA."

NCT04602091 is registered in ClinicalTrials.gov with Societe Francaise de Rhumatologie as lead sponsor.

NCT NCT04602091
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04602091 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
JAKINIB Study: " 'Observational', Multicentre Trial Collecting Prospective and On-going Clinical and Laboratory Data for Patients Treated With JAK Inhibitors for Inflammatory Rheumatism According to EMA."
Lead sponsor
Societe Francaise de Rhumatologie
Phase
Observational
Overall status
Active, not recruiting
Start date
October 8, 2019
Completion date
June 30, 2030
Enrollment
2,300 (estimated)
Sites
60

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory rheumatism, psoriatic arthritis, rheumatoid arthritis, spondyloarthritis